v3.25.2
Acquisitions, Dispositions, and Funded Research and Development Arrangements (Tables)
 12 Months Ended
Apr. 25, 2025
Business Combination, Asset Acquisition, and Joint Venture Formation [Abstract]  
Schedule of Reconciliation of Beginning and Ending Balances of Contingent Consideration Associated with Acquisitions
The following table provides a reconciliation of the beginning and ending balances of contingent consideration liabilities:
 Fiscal Year
(in millions)20252024
Beginning Balance$149 $206 
Purchase price contingent consideration20 30 
Payments(86)(104)
Change in fair value(2)18 
Ending Balance$81 $149 
The following table provides a reconciliation of the beginning and ending balances of the Level 3 measurement of contingent consideration receivable:
Fiscal Year
(in millions)20252024
Beginning balance$58 $195 
Change in fair value(45)(138)
Ending balance$13 $58 
Schedule of Significant Unobservable Inputs
The recurring Level 3 fair value measurements of contingent consideration for which a liability is recorded include the following significant unobservable inputs:
(in millions)Fair Value at April 25, 2025Unobservable InputRange
Weighted Average (1)
Revenue and other performance-based payments$54 Discount rate
16.5% - 28.2%
23.1%
Projected fiscal year of payment2026 - 20292027
Product development and other milestone-based payments$27 Discount rate
5.5%
5.5%
Projected fiscal year of payment2026 - 20282027
(1)Unobservable inputs were weighted by the relative fair value of the contingent consideration liability. For projected fiscal year of payment, the amount represents the median of the inputs and is not a weighted average.